MX9206160A - COMPOSITION - Google Patents

COMPOSITION

Info

Publication number
MX9206160A
MX9206160A MX9206160A MX9206160A MX9206160A MX 9206160 A MX9206160 A MX 9206160A MX 9206160 A MX9206160 A MX 9206160A MX 9206160 A MX9206160 A MX 9206160A MX 9206160 A MX9206160 A MX 9206160A
Authority
MX
Mexico
Prior art keywords
physiologically acceptable
skin
carrier medium
glycols
acceptable
Prior art date
Application number
MX9206160A
Other languages
Spanish (es)
Inventor
Ian Flockhart
Ali Altunkaya
Original Assignee
Ian Flockhart
Ali Altunkaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919122765A external-priority patent/GB9122765D0/en
Priority claimed from GB919122767A external-priority patent/GB9122767D0/en
Priority claimed from GB929203272A external-priority patent/GB9203272D0/en
Application filed by Ian Flockhart, Ali Altunkaya filed Critical Ian Flockhart
Publication of MX9206160A publication Critical patent/MX9206160A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Abstract

La presente invención se refiere a una composición para aplicación tópica a la piel de una persona, la cual comprende un medio portador dermatológicamente aceptable, caracterizada en que el medio portador comprende como componentes esenciales cuando menos tres ingredientes seleccionados del tipo que consiste de: a) polialquileno-éter-glicol o alquileno-glicol o mezclas de esos éterglicoles y/o glicoles, fisiológicamente aceptables; b) un alcohol monohídrico alifático C8 - C14 fisiológicamente aceptable; c) un extracto de planta fisiológicamente aceptable que tenga propiedades antifugales y/o antibacterianas a niveles de dosificación fisiológicamente aceptables; y d) un material farmacéuticamente aceptable que tenga propiedades humectantes para la piel.The present invention relates to a composition for topical application to the skin of a person, which comprises a dermatologically acceptable carrier medium, characterized in that the carrier medium comprises as essential components at least three selected ingredients of the type consisting of: a) polyalkylene ether glycol or alkylene glycol or mixtures of those ether glycols and / or glycols, physiologically acceptable; b) a physiologically acceptable C8-C14 aliphatic monohydric alcohol; c) a physiologically acceptable plant extract having antifugal and / or antibacterial properties at physiologically acceptable dosage levels; and d) a pharmaceutically acceptable material having wetting properties for the skin.

MX9206160A 1991-10-26 1992-10-26 COMPOSITION MX9206160A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919122765A GB9122765D0 (en) 1991-10-26 1991-10-26 Composition
GB919122767A GB9122767D0 (en) 1991-10-26 1991-10-26 Composition
GB929203272A GB9203272D0 (en) 1992-02-15 1992-02-15 Composition

Publications (1)

Publication Number Publication Date
MX9206160A true MX9206160A (en) 1993-08-01

Family

ID=27265905

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206160A MX9206160A (en) 1991-10-26 1992-10-26 COMPOSITION

Country Status (4)

Country Link
EP (1) EP0609330A1 (en)
AU (1) AU2783092A (en)
MX (1) MX9206160A (en)
WO (1) WO1993007901A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1305303B1 (en) * 1999-03-10 2001-05-04 Farmigea Spa USE OF NIAOULI ESSENTIAL OIL AS A PROMOTER FOR TRANSDERMAL PERMEAZION.
DE19929197A1 (en) * 1999-06-25 2000-12-28 Novosis Pharma Ag Transdermal systems for the delivery of 5-HT3 receptor antagonists and their use for antiemitic treatment
DE19934523A1 (en) * 1999-07-22 2001-01-25 Novosis Pharma Ag Transdermal systems for the delivery of muscarinic receptor antagonists and their use for the treatment of spasms of smooth muscles in the urological area
US8501245B2 (en) * 2000-12-05 2013-08-06 Morinda, Inc. Selectively inhibiting estrogen production and providing estrogenic effects in the human body
EP1778361A4 (en) 2004-07-29 2012-04-04 Reeve Tammy Rene Antimicrobial and/or antiviral composition and to methods for preparing and administering same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB496893A (en) * 1937-06-08 1938-12-08 Robert Edwin Goldsbrough Vegetable oil preparations for external application to the body
NL281225A (en) * 1961-07-20
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4797402A (en) * 1987-06-02 1989-01-10 Dorsey Kenneth E Cooling anti-itch skin preparations

Also Published As

Publication number Publication date
AU2783092A (en) 1993-05-21
WO1993007901A1 (en) 1993-04-29
EP0609330A1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
UY23635A1 (en) PROCEDURE FOR THE PREPARATION OF PEG INTERFERON CONJUGATES
CO5160321A1 (en) NEW COMPOSITIONS OF TIPRANAVIR AND RITONAVIR
AR021539A1 (en) TOPIC ANHYDRING PREPARATIONS FOR SKIN
ES2173978T3 (en) USE OF AN UNSATURATED FAT ALCOHOL.
ES2147538B1 (en) A CAPILLARY LOTION WITH IMPROVED PROPERTIES IN ITS HAIR PROTECTIVE AND PREVENTIVE ACTION OF HIS FALL, AND REDUCTION OF THE EXTERNAL EFFECTS OF ANDROGENETIC ALOPECIA AND WITH THAT OF THE HAIR FALL.
BR0008453A (en) Synergistically anti-tumor composition
BR9306768A (en) Extendable absorbent article and structure
ES2190195T3 (en) USE OF AT LEAST A PROTEIC EXTRACT OF GRAIN GRAINS FROM GENDER MORINGA AND COSMETIC AND / OR PHARMACEUTICAL COMPOSITION CORRESPONDING.
ES2145557T3 (en) WATER SOFTENING COMPOSITIONS AND DETERGENT COMPOSITIONS.
ES2084168T3 (en) ANTIMALARIC COMPOSITIONS.
PT874640E (en) CYCLOSPORINE FORMULATIONS
MX9206160A (en) COMPOSITION
WO2000033794A3 (en) Oil baths
ES2178653T3 (en) NEW PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING CYCLOSPORINE.
CO5160318A1 (en) PRECURSORY COMPOSITION TO PREPARE A DIALYTIC
AR012546A1 (en) USE OF AT LEAST ONE SELECTED COMPOUND BETWEEN THE GROUP COMPRISING THE SOGAOLS AND THE GINGEROLES FOR THE PREPARATION OF A COMPOSITION DEODORANTE, SOGAOL, GROSS EXTRACT AND PURIFIED EXTRACT CONTAINING THE SOGAOL AND THE DEODANT COMPOSITION.
AR032545A1 (en) PARASITICIDE COMPOSITIONS AND METHODS OF USE
ATE223221T1 (en) SOLUBLE MEDICINAL COMPOSITIONS CONTAINING 2-CHLORO-2'-DEOXYADENOSINE
ES2129893T3 (en) DINUCLEOSIDE-5 ', 5'-PYROPHOSPHATES.
AR029779A1 (en) COMPOSITION AND PROCEDURE FOR DECOLORATION OF KERATIN FIBERS THAT INCLUDES AN ASSOCIATION OF TWO POLYURETHANE POLYETERS AND DEVICE OF TWO COMPARTMENTS FOR SUCH DECOLORATION
MX9206158A (en) DRUG COMPOSITION.
MX9306540A (en) CUSHIONING CREAM OR WITH CUSHING CAPACITY, FOR THE SKIN, AGAINST LACOMEZON OR DERMATITIS CAUSED BY THE DIAPER.
GR3002420T3 (en) Medicinal formulation
HK1045813A1 (en) Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract.
AR024497A1 (en) COSMETIC COMPOSITIONS FOR SKIN CARE CONTAINING CUMIC ALCOHOL